GlassScriptPhysician profile
Federico L Mattioli
NPI 1861617458
$7,768.50
in general payments reported to CMS, 2019-2025
28 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,846 · 2020: $473 · 2021: $926 · 2022: $1,825 · 2023: $1,032 · 2024: $608 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,664 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,663.59 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $964.55 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $752.63 | 2022-2025 | Tecnis Iol, Tecnis Iol, Amo Phaco Needle |
| Eyevance Pharmaceuticals LLC | $654.10 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $565.70 | 2024-2025 | Xdemvy |
| Abbvie INC. | $505.39 | 2022-2023 | |
| Carl Zeiss Meditec USA, INC. | $497.11 | 2021-2025 | Visumax |
| Beaver-Visitec International, INC. | $445.30 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $414.64 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $392.17 | 2019-2021 | |
| Lumenis Be INC | $342.93 | 2023 | Optilight |
| Biotissue Holdings INC. | $318.35 | 2019-2024 | |
| Rxsight INC | $315.55 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $286.02 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $271.88 | 2020-2025 | Photrexa Viscous and Photrexa |
| Allergan, INC. | $190.38 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $149.47 | 2024 | Envista Mx60 Iol, Ic-8 Apthera Iol, Vyzulta |
| Shire North American Group INC | $127.39 | 2019 | |
| Alnylam Pharmaceuticals INC. | $125.01 | 2024 | Amvuttra |
| Kala Pharmaceuticals, INC. | $111.99 | 2020-2022 | |
| Abbott Laboratories | $80.82 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Alcon Vision LLC | $67.84 | 2022-2023 | Rocklatan |
| Rayner Intraocular Lenses Limited | $40.80 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Tearlab Corp | $36.17 | 2022-2023 | Tearlab Osmolarity System |
| Ziemer USA | $29.57 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.82 | 2019 | |
| Sun Pharmaceutical Industries INC. | $23.80 | 2021 | |
| Aerie Pharmaceuticals, INC. | $21.70 | 2019 | |
| Sight Sciences, INC. | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Mattioli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.